TINIMARK

This brand name is authorized in Nigeria.

Active ingredients

The drug TINIMARK contains one active pharmaceutical ingredient (API):

1	Tinidazole UNII 033KF7V46H - TINIDAZOLE
	Tinidazole is active against both protozoa and obligate anaerobic bacteria. The activity against protozoa involves Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The mode of action of tinidazole against anaerobic bacteria and protozoa involves penetration of the drug into the cell of the micro-organism and subsequent damage of DNA strands or inhibition of their synthesis.
	Read more about Tinidazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-8150	Intravenous infusion	Tinimark (Tinidazole Intravenous Infusion 200 mg/100 mL) INJ_SOL 0.2% w/v 400mL x 1's	Intravenous Infusion	26/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XD02	Tinidazole	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XD Imidazole derivatives
Discover more medicines within J01XD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-8150